Cargando…
Thrombocytopenia induced by dabigatran: two case reports
BACKGROUND: Vitamin K inhibitors (e.g. warfarin) and indirect thrombin inhibitors (e.g. heparin) are widely used to prevent thromboembolic disorders (e.g. myocardial infarction, venous thromboembolism, and stroke). These agents have been mainstays of anticoagulation for people older than 60 years. H...
Autores principales: | Kang, Hyun Goo, Lee, Seung Jae, Chung, Ji Yeon, Cheong, Jin Sung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492117/ https://www.ncbi.nlm.nih.gov/pubmed/28662704 http://dx.doi.org/10.1186/s12883-017-0900-8 |
Ejemplares similares
-
Dabigatran approaching the realm of heparin-induced thrombocytopenia
por: Ho, Patricia J, et al.
Publicado: (2016) -
Simultaneous Pancreas-Kidney Transplantation in a Patient with Heparin-Induced Thrombocytopenia on Dabigatran Therapy
por: Jóźwik, Agnieszka, et al.
Publicado: (2018) -
Myasthenia gravis following human papillomavirus vaccination: a case report
por: Chung, Ji Yeon, et al.
Publicado: (2018) -
Dabigatran Acylglucuronide, the Major Metabolite of Dabigatran, Shows a Weaker Anticoagulant Effect than Dabigatran
por: Kim, Jong-Min, et al.
Publicado: (2022) -
Lithium induced reversible Splenial lesion in neuroleptic malignant syndrome like symptoms: two case reports
por: Ryu, Han Uk, et al.
Publicado: (2020)